{
    "organizations": [],
    "uuid": "ea923e7b60f6e80b304829b33f0582632380b1df",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/02/09/globe-newswire-lemaitre-vascular-will-announce-fourth-quarter-2017-earnings-results-on-february-21-2018.html",
    "ord_in_thread": 0,
    "title": "LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.\nAccess to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 9114999. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor .\nAbout LeMaitre Vascular\nLeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. can be found at www.lemaitre.com .\nLeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.\nLeMaitre Vascular, Inc.\nSteven Chehames\nInvestor Relations\n+1-781-425-1659\nschehames@lemaitre.com\nhttp://www.lemaitre.com\nSource:LeMaitre Vascular, Inc.",
    "published": "2018-02-09T16:00:00.000+02:00",
    "crawled": "2018-02-09T16:39:07.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "burlington",
        "globe",
        "newswire",
        "lemaitre",
        "vascular",
        "nasdaq",
        "lmat",
        "announced",
        "today",
        "release",
        "fourth",
        "quarter",
        "financial",
        "result",
        "wednesday",
        "february",
        "market",
        "close",
        "company",
        "scheduled",
        "conference",
        "call",
        "pm",
        "est",
        "day",
        "discus",
        "result",
        "business",
        "highlight",
        "company",
        "outlook",
        "access",
        "live",
        "call",
        "available",
        "dialing",
        "international",
        "caller",
        "passcode",
        "call",
        "also",
        "accessed",
        "live",
        "via",
        "replay",
        "webcast",
        "lemaitre",
        "vascular",
        "lemaitre",
        "vascular",
        "provider",
        "device",
        "implant",
        "service",
        "treatment",
        "peripheral",
        "vascular",
        "disease",
        "condition",
        "affect",
        "million",
        "people",
        "worldwide",
        "company",
        "develops",
        "manufacture",
        "market",
        "disposable",
        "implantable",
        "vascular",
        "device",
        "address",
        "need",
        "core",
        "customer",
        "vascular",
        "surgeon",
        "company",
        "diversified",
        "product",
        "portfolio",
        "consists",
        "brand",
        "name",
        "device",
        "used",
        "artery",
        "vein",
        "outside",
        "heart",
        "found",
        "lemaitre",
        "lemaitre",
        "vascular",
        "logo",
        "registered",
        "trademark",
        "lemaitre",
        "vascular",
        "lemaitre",
        "vascular",
        "steven",
        "chehames",
        "investor",
        "relation",
        "schehames",
        "http",
        "source",
        "lemaitre",
        "vascular",
        "inc"
    ]
}